CANDEL THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.02 USD | +7.00% |
|
+41.16% | +513.61% |
| 11/04 | Sector Update: Health Care Stocks Decline Thursday Afternoon | MT |
| 11/04 | Candel Therapeutics Shares Rise After FDA Orphan Drug Designation for Potential Pancreatic Cancer Drug | MT |
Chart calendar Candel Therapeutics, Inc.
7f0f4029f60f22c5.j8erGysiVYXc2ALAauag7SEiVUNgR5sT4FiTwBbSUT0.1-rZT0FvPcmNm1e5GNP1i2hoHgwGcs9fv2zfl3CBFHXHqedYXWY75K27cQ~25df243d729c871c789042a546d16c60
Upcoming events on Candel Therapeutics, Inc.
Past events on Candel Therapeutics, Inc.
| 09/04/2024 09:30 pm | American Association for Cancer Research Meeting - Abstract No - LB263 |
| 28/03/2024 05:35 pm | Q4 2023 Earnings Release |
| 28/03/2024 | Glioblastoma Drug Development Summit |
| 09/11/2023 06:30 pm | Q3 2023 Earnings Release |
| 04/11/2023 09:30 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number :1096 |
| 04/11/2023 09:30 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number :1348 |
| 03/11/2023 09:30 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number :653 |
| 12/09/2023 12:30 am | H.C. Wainwright Global Investment Conference |
| 10/08/2023 09:00 pm | Canaccord Genuity Growth Conference |
| 10/08/2023 05:30 pm | Q2 2023 Earnings Release |
| 28/06/2023 07:30 pm | Annual General Meeting |
| 08/06/2023 01:30 am | Jefferies Global Healthcare Conference |
| 04/06/2023 06:30 pm | American Society of Clinical Oncology Conference - Charu Aggarwal |
| 19/05/2023 08:30 pm | American Society of Gene Cell Therapy Meeting - Francesca Barone |
| 11/05/2023 05:30 pm | Q1 2023 Earnings Release |
| 30/03/2023 05:30 pm | Q4 2022 Earnings Release |
| 09/02/2023 01:50 am | Guggenheim Oncology Conference |
| 19/01/2023 10:00 pm | B. Riley Securities Oncology Conference |
| 06/12/2022 09:30 pm | R&D Day |
| 19/11/2022 04:00 am | Society for Neuro-Oncology Meeting |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,13 0,03 278.79% | 0,13 0,11 15.39% | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -25,5 -24,0 -6.44% | -33,9 -37,1 8.58% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -25,7 -26,4 2.59% | -34,7 -36,4 4.57% | -38,4 -37,3 -2.92% | -46,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -36,1 -47,5 23.95% | -18,8 -21,8 13.59% | -37,9 -31,6 -20.06% | -41,6 |
|
Net income Million USD | Released Forecast Spread | -36,1 -40,7 11.24% | -18,8 -21,8 13.59% | -37,9 -31,6 -20.06% | -41,6 |
|
EPS USD | Released Forecast Spread | -1,91 -2,14 10.9% | -0,65 -0,70 7.75% | -1,31 -1,09 -20.18% | -0,91 |
| Announcement Date | 29/03/22 | 30/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,03 0,02 106.67% | 0,03 0,02 100% | 0,03 0,00 - | 0,03 0,01 200.1% | 0,03 0,01 121.43% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | |
|
EBITDA Million USD | Released Forecast Spread | -7,56 -7,45 -1.55% | -8,82 -7,64 -15.52% | -8,57 -5,76 -48.61% | -8,68 -8,19 -5.89% | -7,88 | ||||
|
EBIT Million USD | Released Forecast Spread | -7,74 -8,24 6.01% | -8,99 -10,9 17.84% | -8,75 -13,8 36.53% | -8,88 -11,7 24.23% | -8,10 -11,7 30.54% | -9,63 -10,0 3.67% | -9,58 -11,1 13.31% | -8,86 -9,90 10.49% | -10,3 -9,20 -12.15% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,08 -4,80 -5.9% | -9,61 -6,60 -45.67% | -8,44 -5,40 -56.2% | -11,1 -4,70 -136.06% | |||||
|
Net income Million USD | Released Forecast Spread | 1,60 -9,00 117.73% | -0,87 -14,2 93.85% | -4,15 -16,0 74.07% | -8,69 -16,0 45.7% | -5,08 -4,80 -5.9% | -9,61 -6,60 -45.67% | -8,44 -5,40 -56.2% | -11,1 -4,70 -136.06% | |
|
EPS USD | Released Forecast Spread | 0,51 -0,35 244.58% | -0,03 -0,34 91.1% | -0,14 -0,45 69.12% | -0,30 -0,36 16.48% | -0,17 -0,31 44.33% | -0,30 -0,35 14.29% | -0,33 -0,30 -10% | -0,29 -0,19 -52.63% | -0,38 -0,16 -137.5% |
| Announcement Date | 29/03/22 | 12/05/22 | 05/08/22 | 10/11/22 | 30/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 28/03/24 |
| 07/05/2024 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
| 07/05/2024 | VERVE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | OLEMA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | BEAM THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | PHARVARIS N.V.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | IDEAYA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | SANA BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | NOVAVAX, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 10:30 am | VALNEVA: Q1 2024 Earnings Release |
| 07/05/2024 04:30 pm | IONIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Past sector events for Candel Therapeutics, Inc.
| 03/05/2024 01:40 am | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 05:30 pm | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:35 pm | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:00 pm | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CADL Stock
- Calendar Candel Therapeutics, Inc.
